New Haven

The museum plans to acquire a vacant industrial building at 60 Hamilton St., in the city’s Mill River District.

Veradermics Inc., a New Haven-based biopharmaceutical startup developing an oral treatment for pattern hair loss, has filed for an initial public offering.

The number of Connecticut municipalities suing major insulin manufacturers and pharmacy benefit managers over price-fixing continues to grow.

New Haven-based Biohaven Ltd. said Tuesday it expects to raise about $125 million via the sale of common shares to Janus Henderson Investors.

Founder and chief scientist, Yale professor Rob Schoelkopf, will run a research and development center for the combined company in New Haven.

Now the CSCU Center for Quantum and Nanotechnology, or QNT, the facility will serve as a hub for quantum workforce development.

Community Foundation for Greater New Haven is on track to surpass last year's $33.3M fundraising total in CEO Karen DuBois-Walton's first full year. The foundation awarded $31.4M in grants in 2024.

New Haven-based Yale New Haven Health System, the state’s largest health system, announced Tuesday it has hired Chicago-based real estate services firm JLL to manage its expansive real estate portfolio.

New Haven-based Veradermics raised $150M to advance its oral minoxidil pill for hair loss into Phase 3 trials. The biotech, founded by dermatologist Reid Waldman, is recruiting 1,500 patients for the study.

The Hartford-West Hartford-East Hartford metro area is poised to lead the nation’s housing market in 2026, according to Realtor.com’s annual outlook, which showed a sharp geographic shift toward the Northeast and Midwest.